BUSINESSglobal
Ternary Therapeutics targets “undruggable” proteins with AI-designed molecular glues, raising €4.1 million
Single source
Updated 2 hours ago
First seen March 16, 2026 23:10:17Stay on top of this story
Follow the names and topics behind it.
Add this story's key topics to your watchlist so LyscoNews can highlight related developments and future matches.
Create a free account to sync your watchlist, saved stories, and alerts across devices.
Quick Summary
London-based BioTech startup Ternary Therapeutics has raised €4.1 million (£3.6 million) in Seed funding to scale an AI platform designed to create a new class of medicines known as molecular glues. The round was led by European venture firm daphni, with participation from Pace Ventures, the i&i Biotech Fund and the UK Innovation & Science […] The post Ternary Therapeutics targets “undruggable” proteins with AI-designed molecular glues, raising €4.1 million appeared first on EU-Startups.